vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and ONTO INNOVATION INC. (ONTO). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $218.2M, roughly 1.2× ONTO INNOVATION INC.). ONTO INNOVATION INC. runs the higher net margin — 12.9% vs 0.7%, a 12.2% gap on every dollar of revenue. On growth, ONTO INNOVATION INC. posted the faster year-over-year revenue change (-13.5% vs -16.5%). ONTO INNOVATION INC. produced more free cash flow last quarter ($82.0M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Onto Innovation Inc. is an American semiconductor company formed in 2019 from the merger of Rudolph Technologies, Inc. and Nanometrics Incorporated. It is a provider of process and process control equipment and software for microelectronic manufacturing industries.

HCM vs ONTO — Head-to-Head

Bigger by revenue
HCM
HCM
1.2× larger
HCM
$270.8M
$218.2M
ONTO
Growing faster (revenue YoY)
ONTO
ONTO
+3.1% gap
ONTO
-13.5%
-16.5%
HCM
Higher net margin
ONTO
ONTO
12.2% more per $
ONTO
12.9%
0.7%
HCM
More free cash flow
ONTO
ONTO
$78.7M more FCF
ONTO
$82.0M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
HCM
HCM
ONTO
ONTO
Revenue
$270.8M
$218.2M
Net Profit
$2.0M
$28.2M
Gross Margin
37.7%
50.7%
Operating Margin
-13.2%
10.9%
Net Margin
0.7%
12.9%
Revenue YoY
-16.5%
-13.5%
Net Profit YoY
-83.6%
-46.8%
EPS (diluted)
$0.00
$0.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
ONTO
ONTO
Q4 25
$270.8M
Q3 25
$218.2M
Q2 25
$277.7M
$253.6M
Q1 25
$324.5M
$266.6M
Q4 24
$263.9M
Q3 24
$252.2M
Q2 24
$305.7M
$242.3M
Q1 24
$228.8M
Net Profit
HCM
HCM
ONTO
ONTO
Q4 25
$2.0M
Q3 25
$28.2M
Q2 25
$455.0M
$33.9M
Q1 25
$11.9M
$64.1M
Q4 24
$48.8M
Q3 24
$53.1M
Q2 24
$25.8M
$52.9M
Q1 24
$46.9M
Gross Margin
HCM
HCM
ONTO
ONTO
Q4 25
37.7%
Q3 25
50.7%
Q2 25
0.1%
48.2%
Q1 25
48.0%
53.7%
Q4 24
50.2%
Q3 24
54.1%
Q2 24
41.1%
52.9%
Q1 24
51.7%
Operating Margin
HCM
HCM
ONTO
ONTO
Q4 25
-13.2%
Q3 25
10.9%
Q2 25
-1.3%
12.7%
Q1 25
-5.0%
23.7%
Q4 24
16.1%
Q3 24
21.0%
Q2 24
-9.0%
20.2%
Q1 24
18.7%
Net Margin
HCM
HCM
ONTO
ONTO
Q4 25
0.7%
Q3 25
12.9%
Q2 25
163.8%
13.4%
Q1 25
3.7%
24.0%
Q4 24
18.5%
Q3 24
21.0%
Q2 24
8.4%
21.9%
Q1 24
20.5%
EPS (diluted)
HCM
HCM
ONTO
ONTO
Q4 25
$0.00
Q3 25
$0.57
Q2 25
$0.52
$0.69
Q1 25
$0.01
$1.30
Q4 24
$0.98
Q3 24
$1.07
Q2 24
$0.03
$1.07
Q1 24
$0.94

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
ONTO
ONTO
Cash + ST InvestmentsLiquidity on hand
$1.4B
$603.1M
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$2.0B
Total Assets
$1.8B
$2.2B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
ONTO
ONTO
Q4 25
$1.4B
Q3 25
$603.1M
Q2 25
$1.4B
$217.5M
Q1 25
$836.1M
$203.7M
Q4 24
$212.9M
Q3 24
$188.7M
Q2 24
$802.5M
$172.6M
Q1 24
$190.9M
Total Debt
HCM
HCM
ONTO
ONTO
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
HCM
HCM
ONTO
ONTO
Q4 25
$1.2B
Q3 25
$2.0B
Q2 25
$1.2B
$2.0B
Q1 25
$759.9M
$1.9B
Q4 24
$1.9B
Q3 24
$1.9B
Q2 24
$740.1M
$1.8B
Q1 24
$1.8B
Total Assets
HCM
HCM
ONTO
ONTO
Q4 25
$1.8B
Q3 25
$2.2B
Q2 25
$1.8B
$2.1B
Q1 25
$1.3B
$2.1B
Q4 24
$2.1B
Q3 24
$2.1B
Q2 24
$1.3B
$2.0B
Q1 24
$2.0B
Debt / Equity
HCM
HCM
ONTO
ONTO
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
ONTO
ONTO
Operating Cash FlowLast quarter
$8.2M
$83.4M
Free Cash FlowOCF − Capex
$3.4M
$82.0M
FCF MarginFCF / Revenue
1.2%
37.6%
Capex IntensityCapex / Revenue
1.8%
0.6%
Cash ConversionOCF / Net Profit
4.21×
2.95×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$261.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
ONTO
ONTO
Q4 25
$8.2M
Q3 25
$83.4M
Q2 25
$-72.9M
$57.9M
Q1 25
$40.3M
$92.0M
Q4 24
$56.0M
Q3 24
$67.2M
Q2 24
$-39.8M
$65.3M
Q1 24
$57.1M
Free Cash Flow
HCM
HCM
ONTO
ONTO
Q4 25
$3.4M
Q3 25
$82.0M
Q2 25
$-82.2M
$44.2M
Q1 25
$32.5M
$83.7M
Q4 24
$51.4M
Q3 24
$59.2M
Q2 24
$-49.9M
$53.0M
Q1 24
$50.2M
FCF Margin
HCM
HCM
ONTO
ONTO
Q4 25
1.2%
Q3 25
37.6%
Q2 25
-29.6%
17.4%
Q1 25
10.0%
31.4%
Q4 24
19.5%
Q3 24
23.5%
Q2 24
-16.3%
21.9%
Q1 24
21.9%
Capex Intensity
HCM
HCM
ONTO
ONTO
Q4 25
1.8%
Q3 25
0.6%
Q2 25
3.3%
5.4%
Q1 25
2.4%
3.1%
Q4 24
1.8%
Q3 24
3.2%
Q2 24
3.3%
5.1%
Q1 24
3.0%
Cash Conversion
HCM
HCM
ONTO
ONTO
Q4 25
4.21×
Q3 25
2.95×
Q2 25
-0.16×
1.71×
Q1 25
3.38×
1.44×
Q4 24
1.15×
Q3 24
1.27×
Q2 24
-1.54×
1.23×
Q1 24
1.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

ONTO
ONTO

Systems And Software Revenue$173.8M80%
Parts Revenue$23.9M11%
Service Revenue$20.5M9%

Related Comparisons